Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation
Continuation of VKA during S-ICD implantation was associated with an increased risk of pocket hematoma formation compared to interruption of VKA. This supports the need for specific perioperative antithrombotic therapy guidelines for S-ICD implantations to reduce the risk of pocket hematomas.
Authors
- A. A. M. Wilde
- Louise R.A. Olde Nordkamp (ORCID: https://orcid.org/0000-0003-2306-603X)
- Lonneke Smeding (ORCID: https://orcid.org/0000-0002-7558-9011)
- N. Kors
- Leonard Alexander Dijkshoorn
- Nick R. Bijsterveld (ORCID: https://orcid.org/0000-0002-9792-3359)
- Jolien A. de Veld (ORCID: https://orcid.org/0009-0004-4200-8075)
- Shari Pepplinkhuizen (ORCID: https://orcid.org/0000-0001-7530-7048)
- Reinoud E. Knops (ORCID: https://orcid.org/0000-0002-0772-3573)
- Arend de Weger (ORCID: https://orcid.org/0000-0002-4190-3156)
Institutions
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1007/s10840-024-01973-x
- Citations
- 2
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 2.78